ASX & Media Release
Patrys Presenting at Biotech Showcase
Melbourne, Australia; 8 January, 2019: Patrys Limited (ASX: PAB), a therapeutic antibody development company, advises that its CEO and Managing Director, Dr. James Campbell will present an overview of the company and its technologies at the Biotech ShowcaseTM Annual Conference in San Francisco.
The presentation will be at 4:30pm PST on Tuesday 8th January, 2019 at the Hilton San Francisco Union Square in the Yosemite - A room.
Biotech ShowcaseTM is devoted to biotechnology companies and coincides with the 37th Annual JP Morgan Healthcare Conference and associated life sciences investment and partnering meetings.
The Biotech ShowcaseTM is expected to attract over 3,600 attendees, including 400 presenting companies and over 900 investors.
-Ends-
For further information, please contact:
Patrys Limited: | Patrys IR: |
James Campbell | Ben Walsh |
Chief Executive Officer | WE Buchan |
P: +61 3 96703273 | P: +61 2 9237 2801 |
info@patrys.com | bwalsh@buchanwe.com.au |
About Patrys Limited: |
Based in Melbourne, Australia, Patrys (ASX: PAB) is focused on the development of antibodies as therapies for a range of different cancers. Patrys has a pipeline of anti-cancer antibodies for both internal development and as partnering opportunities. More information can be found atwww.patrys.com.
1
Attachments
- Original document
- Permalink
Disclaimer
Patrys Limited published this content on 08 January 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 08 January 2019 00:18:05 UTC